FormWeb • phenytoin

Oregon Department of Corrections

Approved Formulary

QR Code

Add Formweb to your mobile device

Android iOS

February P&T meeting minutes have been posted.

Oregon Department of Corrections

Approved Formulary

Search results for:

phenytoin

phenytoin

Hazardous Drugs Handling Guide (Group 2: Non-Antineoplastic)
Cell Status NFISA

Brand names: DILANTIN, Phenytoin Sodium, Extended Release, Phenytoin Sodium, Prompt

Form	Strength
CAPSULE, EXTENDED RELEASE, ORAL	100 mg
SOLUTION, INJECTABLE	50 mg/mL
SUSPENSION, ORAL	25 mg/mL

Additional Information:

OCTOBER 2021 P&T MINUTES

JUNE 2019 P&T MINUTES

FEBRUARY 2014 P&T MINUTES

JANUARY 2011 P&T MINUTES

Last updated: Mar. 10, 2023

Black Box Warning: Cardiovascular risk with rapid infusion
FDA Drug Safety: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research for Dilantin - 125 (phenytoin) Oral Suspension and Dilantin (phenytoin) Injection

This site is intended for the staff of Oregon Department of Corrections.
While others may view accessible pages, Oregon Department of Corrections makes no warranty, express or implied,
as to the use of this information outside of Oregon Department of Corrections.

Copyright © 2024 Rpharmy, LLC All Rights Reserved